Unigene negotiates forbearance with Victory Park Capital Advisors

Company gets $4 million via one-year senior secured convertible note

By Devika Patel

Knoxville, Tenn., Nov. 21 - Unigene Laboratories, Inc. said it has negotiated a forbearance agreement with Victory Park Capital Advisors, LLC on Sept. 21. The investor loaned the company $4 million.

The investor agreed to forbear from exercising its rights concerning events of default through Sept. 21, 2013.

Under the agreement, Unigene issued a $4 million one-year senior secured convertible note to an affiliate of Victory Park Capital Advisors, LLC. The note bears interest at a rate per annum equal to the greater of Prime plus 500 basis points or 15%.

The new debt converts to common shares at $0.05 per share, while the existing debt now converts into shares at $0.15 per share.

Proceeds were used for fees and expenses and will also be used to finance operations.

Fairfield, N.J.-based Unigene is a biopharmaceutical company focusing on the oral and nasal delivery of large-market peptide drugs.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.